title: Efficacy and tolerability of the new antiepileptic drugs: commentary on the recently published practice parameters.
authors.forename: Chrystostomos P
authors.initials: CP
authors.lastname: Panayiotopoulos
authors.forename: Selim R
authors.initials: SR
authors.lastname: Benbadis
authors.forename: Anthanasios
authors.initials: A
authors.lastname: Covanis
authors.forename: Olivier
authors.initials: O
authors.lastname: Dulac
authors.forename: John S
authors.initials: JS
authors.lastname: Duncan
authors.forename: Orvar
authors.initials: O
authors.lastname: Eeg-Olofsson
authors.forename: Colin D
authors.initials: CD
authors.lastname: Ferrie
authors.forename: Richard A
authors.initials: RA
authors.lastname: Grünewald
authors.forename: Dorothee G A
authors.initials: DG
authors.lastname: Kasteleijn-Nolst Trenite
authors.forename: Michael
authors.initials: M
authors.lastname: Koutroumanidis
authors.forename: Zarko
authors.initials: Z
authors.lastname: Martinovic
authors.forename: Richard W
authors.initials: RW
authors.lastname: Newton
authors.forename: Alasdair P
authors.initials: AP
authors.lastname: Parker
authors.forename: Janvier
authors.initials: J
authors.lastname: Salas-Puig
authors.forename: J W A S
authors.initials: JW
authors.lastname: Sander
authors.forename: Simon
authors.initials: S
authors.lastname: Shorvon
authors.forename: Kazuyoshi
authors.initials: K
authors.lastname: Watanabe
authors.forename: William P
authors.initials: WP
authors.lastname: Whitehouse
authors.forename: Sotirios
authors.initials: S
authors.lastname: Youroukos
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D004827:Epilepsy / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards*; D009626:Terminology as Topic; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants